We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Neuroprotective compounds from marine invertebrates
Summary
Researchers reviewed biologically active compounds found in marine invertebrates like sponges, sea cucumbers, and coral, many of which show potential for treating neuroinflammatory diseases such as Alzheimer's and Parkinson's by targeting key proteins involved in brain inflammation and cell death. While promising, the review notes that challenges around sustainable sourcing and the need for more clinical trials remain significant hurdles before these marine compounds reach patients.
Abstract Background Neuroinflammation is a key pathological feature of a wide variety of neurological disorders, including Parkinson’s, multiple sclerosis, Alzheimer’s, and Huntington’s disease. While current treatments for these disorders are primarily symptomatic, there is a growing interest in developing new therapeutics that target the underlying neuroinflammatory processes. Main body Marine invertebrates, such as coral, sea urchins, starfish, sponges, and sea cucumbers, have been found to contain a wide variety of biologically active compounds that have demonstrated potential therapeutic properties. These compounds are known to target various key proteins and pathways in neuroinflammation, including 6-hydroxydopamine (OHDH), caspase-3 and caspase-9, p-Akt, p-ERK, p-P38, acetylcholinesterase (AChE), amyloid-β (Aβ), HSF-1, α-synuclein, cellular prion protein, advanced glycation end products (AGEs), paraquat (PQ), and mitochondria DJ-1. Short conclusion This review focuses on the current state of research on the neuroprotective effects of compounds found in marine invertebrates and the potential therapeutic implications of these findings for treating neuroinflammatory disorders. We also discussed the challenges and limitations of using marine-based compounds as therapeutics, such as sourcing and sustainability concerns, and the need for more preclinical and clinical studies to establish their efficacy and safety. Graphical abstract
Sign in to start a discussion.
More Papers Like This
Petrosamine isolated from marine sponge Petrosia sp. demonstrates protection against neurotoxicity in vitro and in vivo
Researchers isolated a compound called petrosamine from a Brazilian marine sponge and tested its ability to protect against neurotoxicity in both human neuroblastoma cells and zebrafish embryos, finding it showed promise against hallmarks of Alzheimer's disease. The results suggest that ocean-derived compounds may offer new avenues for developing treatments for neurodegenerative diseases.
Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer’s Disease
Researchers reviewed natural bioactive compounds from plant sources for their potential neuroprotective effects related to Alzheimer's disease. The study highlights how these compounds may modulate molecular mechanisms involved in disease development, while noting challenges such as limited bioavailability and blood-brain barrier permeability.
Marine Ecological Well-Being and the Development of Human Health Through Marine Natural Products and Nutraceuticals
This review examines the balance between marine ecological health and the development of nutraceuticals and functional foods from ocean species. The study discusses how pollution including microplastics threatens marine ecosystems while also covering the bioactive compounds from marine organisms that show potential antioxidant, cardio-protective, and neuroprotective properties.
Uncovering the impact of nano- and microplastics on neurodegenerative diseases and strategies to mitigate their damage
Researchers reviewed evidence that micro- and nanoplastics may contribute to the progression of Alzheimer's and Parkinson's diseases by triggering brain inflammation, disrupting mitochondria (the cell's power source), and damaging the blood-brain barrier. The review also found that natural compounds like melatonin and probiotics show early promise in reducing some of these harmful effects.
Challenges and Future Prospects: A Benefaction of Phytoconstituents on Molecular Targets Pertaining to Alzheimer’s Disease
This review explores the potential of plant-derived compounds as therapeutic agents for Alzheimer's disease, examining how various phytochemicals interact with molecular targets involved in the condition. Researchers summarize evidence on natural compounds that may help address inflammation, oxidative stress, and protein buildup in the brain. The study highlights the need for further research to translate these preliminary findings into viable treatment approaches.